Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for Relapse Prevention in TRD
NCT02772211Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Jun 2016
- Primary completion
- Dec 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing D-cycloserine with Placebo (2 arms). Primary endpoint: Montgomery Asberg Depression Scale. Status: unknown.
02
Drugs
d-cycloserine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02772211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772211.